295 related articles for article (PubMed ID: 26248894)
21. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
22. Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias.
Dunphy CH; O'Malley DP; Perkins SL; Chang CC
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):154-9. PubMed ID: 17525626
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of bone marrow aspirates in patients with acute myeloid leukemia at day 14 of induction therapy.
Souto Filho JT; Loureiro MM; Pulcheri W; Morais JC; Nucci M; Portugal RD
Diagn Pathol; 2015 Jul; 10():122. PubMed ID: 26205005
[TBL] [Abstract][Full Text] [Related]
24. Chemosensitivity of nonleukemic clonogenic precursors in AML patients in complete remission: association with CD34(+) mobilization and with disease-free survival.
Milone G; Avola G; Leotta S; Strano A; Camuglia MG; Pinto V; Mercurio S; Poidomani M; Coppoletta S; Di Marco AL; Consoli C; Triolo A; Spadaro A; Privitera A; Ragusa A; Tibullo D; Di Mercurio S
Exp Hematol; 2012 Jan; 40(1):35-47.e2. PubMed ID: 22019627
[TBL] [Abstract][Full Text] [Related]
25. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.
Loken MR; Chu SC; Fritschle W; Kalnoski M; Wells DA
Cytometry B Clin Cytom; 2009 Jan; 76(1):27-36. PubMed ID: 18548614
[TBL] [Abstract][Full Text] [Related]
26. Podocalyxin: a marker of blasts in acute leukemia.
Kelley TW; Huntsman D; McNagny KM; Roskelley CD; Hsi ED
Am J Clin Pathol; 2005 Jul; 124(1):134-42. PubMed ID: 15923169
[TBL] [Abstract][Full Text] [Related]
27. Prognostic and Therapeutic Value of Day 14 Bone Marrow Aspiration in Adult Acute Myeloid Leukemia Patients.
El Gammal MM; Owaidat HM; Rashed RA; Fatah RA; Samra MA
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e406-e413. PubMed ID: 31031147
[TBL] [Abstract][Full Text] [Related]
28. The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; the results of multicenter, prospective Polish Adult Leukemia Group study.
Grosicki S; Holowiecki J; Giebel S; Kyrcz-Krzemien S; Kuliczkowski K; Kielbinski M; Skotnicki AB; Piatkowska-Jakubas B; Hellmann A; Wierzbowska A; Stella-Holowiecka B; Zdziarska B; Calbecka M
Am J Hematol; 2011 May; 86(5):437-9. PubMed ID: 21465518
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
30. Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease.
Ollila TA; Olszewski AJ; Butera JN; Quesenberry MI; Quesenberry PJ; Reagan JL
Clin Lymphoma Myeloma Leuk; 2018 Mar; 18(3):204-209. PubMed ID: 29433979
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and therapeutic implications of early treatment response assessment in acute myeloid leukemia.
Pullarkat V; Aldoss I
Crit Rev Oncol Hematol; 2015 Jul; 95(1):38-45. PubMed ID: 25624175
[TBL] [Abstract][Full Text] [Related]
32. Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody.
Soligo D; Delia D; Oriani A; Cattoretti G; Orazi A; Bertolli V; Quirici N; Deliliers GL
Leukemia; 1991 Dec; 5(12):1026-30. PubMed ID: 1723130
[TBL] [Abstract][Full Text] [Related]
33. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
[TBL] [Abstract][Full Text] [Related]
34. A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia.
Angelini DF; Ottone T; Guerrera G; Lavorgna S; Cittadini M; Buccisano F; De Bardi M; Gargano F; Maurillo L; Divona M; Noguera NI; Consalvo MI; Borsellino G; Bernardi G; Amadori S; Venditti A; Battistini L; Lo-Coco F
Clin Cancer Res; 2015 Sep; 21(17):3977-85. PubMed ID: 25957287
[TBL] [Abstract][Full Text] [Related]
35. CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes.
Min YH; Lee ST; Min DW; Kim TS; Lee CH; Lee BK; Hahn JS; Ko YW
Yonsei Med J; 1995 Mar; 36(1):1-8. PubMed ID: 7537931
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia.
Covut F; Gupta D; Pinto R; Dambrosio N; El Jurdi N; Meyerson H; Ueda M; Kolk M; Creger R; Metheny L; Cooper BW; Caimi PF; Malek E; Otegbeye F; Lazarus HM; De Lima M; Tomlinson BK
Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):73-82. PubMed ID: 30528848
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis.
Iversen PO; Wiig H
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6793-9. PubMed ID: 16203766
[TBL] [Abstract][Full Text] [Related]
38. The challenging task of enumerating blasts in the bone marrow.
Hodes A; Calvo KR; Dulau A; Maric I; Sun J; Braylan R
Semin Hematol; 2019 Jan; 56(1):58-64. PubMed ID: 30573046
[TBL] [Abstract][Full Text] [Related]
39. Persistent cytogenetic abnormalities in patients undergoing intensive chemotherapy for acute myeloid leukemia.
Saini L; Brandwein J; Szkotak A; Ghosh S; Sandhu I
Leuk Lymphoma; 2018 Jan; 59(1):121-128. PubMed ID: 28540755
[TBL] [Abstract][Full Text] [Related]
40. [Expression of CD133 in bone marrow cells of patients with leukemia and myelodysplastic syndrome].
Wang W; Wang HY; Zhao HX; Cui ZG; Li GL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):470-3. PubMed ID: 17605847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
